dpp4 and glp-1 Expert Consensus on Dipeptidyl Peptidase-4 Inhibitor-Based Therapies in the Modern Era of Type 2 Diabetes Mellitus Management in India Neuroprotection by dipeptidyl-peptidase-4 inhibitors and

Here's what you need to know and how to save 10%.

Andrew Huberman explores how peptides, AI, and emerging technologies are reshaping American health

LMNT reports that GLP-1 medications for obesity and diabetes may lead to electrolyte imbalances, highlighting hydration strategies for users.

Aims/hypothesis Regulators worldwide are reviewing safety data on glucagon-like peptide-1 receptor agonists (GLP-1RA), following reports by the Icelandic Medicines Agency in July 2023 of suicidal ideation and self-injury (SIS) in individuals taking liraglutide and semaglutide

Skvl aukce od 299 K

Learn why mood changes can happen and practical ways to restore energy, balance and motivation.